Saint Martin d'Heres, France

Yung-Sing Wong

This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yung-Sing Wong. Retrieved from https://idiyas.com/inventor/yung-sing-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 4.9

ph-index = 1


Location History:

  • Saint Martin-d'Heres, FR (2013)
  • Saint Martin-d'Hères, FR (2015 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yung-Sing Wong: Innovator in Pharmaceutical Compounds

Introduction

Yung-Sing Wong is a notable inventor based in Saint Martin d'Hères, France. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of inhibitors and cyclic peptides. With a total of 3 patents, Wong's work has the potential to impact the treatment of various pathogenic infections and diseases.

Latest Patents

Wong's latest patents include innovative methods and compounds aimed at addressing critical health challenges. One of his patents focuses on "Pseudomonas aeruginosa inhibitor compounds," which relates to identifying molecules that inhibit the virulence machinery of this pathogenic bacterium. This invention also encompasses pharmaceutical compositions designed for preventing and treating infections caused by Pseudomonas aeruginosa. Another significant patent involves "Cyclic peptides with an anti-parasitic activity." This invention details a method for preparing cyclic peptides that exhibit both anti-parasitic and anti-cancer properties. The cyclic peptide is proposed for use as an antiparasite agent, particularly in the treatment of toxoplasmosis, and as an anticancer agent, with applications for treating organs ex vivo before transplantation.

Career Highlights

Throughout his career, Yung-Sing Wong has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Wong has collaborated with notable colleagues, including Sophie Ple and Ina Attree. These partnerships have facilitated the exchange of ideas and advancements in their respective research areas.

Conclusion

Yung-Sing Wong's innovative work in the development of pharmaceutical compounds showcases his dedication to addressing significant health issues. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…